A recent study suggested that osteoprotegerin (OPG) can regulate CD36 transcription through the ERK-PPARγ pathway, thus promoting hepatic steatosis (Zhang et al., 2019a). The gene discussed is TNFRSF11B; the disease is Hepatic steatosis.